Drug
Thiamine hydrochloride
Thiamine hydrochloride is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
1
25%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed375%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Thiamine as a Renal Protective Agent in Septic Shock
NCT03550794
completedphase_4
Optimum Thiamine Intervention (OpTIn) Trial
NCT02788552
withdrawnnot_applicable
A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs
NCT00037063
completednot_applicable
Vitamin B Therapy for Hyperlactatemia
NCT00031057
Clinical Trials (4)
Showing 4 of 4 trials
NCT03550794Phase 2
Thiamine as a Renal Protective Agent in Septic Shock
NCT02788552Phase 4
Optimum Thiamine Intervention (OpTIn) Trial
NCT00037063Not Applicable
A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs
NCT00031057Not Applicable
Vitamin B Therapy for Hyperlactatemia
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4